SE7614401L - Forfarande for framstellning av natriumcefamandolanhydrat i kristalliserad form - Google Patents

Forfarande for framstellning av natriumcefamandolanhydrat i kristalliserad form

Info

Publication number
SE7614401L
SE7614401L SE7614401A SE7614401A SE7614401L SE 7614401 L SE7614401 L SE 7614401L SE 7614401 A SE7614401 A SE 7614401A SE 7614401 A SE7614401 A SE 7614401A SE 7614401 L SE7614401 L SE 7614401L
Authority
SE
Sweden
Prior art keywords
sodium
camphandolanhydrate
procedure
production
crystalized form
Prior art date
Application number
SE7614401A
Other languages
Unknown language ( )
English (en)
Other versions
SE424730B (sv
Inventor
Kuo Shang Yang
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE7614401L publication Critical patent/SE7614401L/sv
Publication of SE424730B publication Critical patent/SE424730B/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7614401A 1975-12-22 1976-12-21 Forfarande for framstellning av natriumcefamandolanhydrat i kristalliserad form SE424730B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/642,922 US4054738A (en) 1975-12-22 1975-12-22 Sodium cefamandole crystalline forms

Publications (2)

Publication Number Publication Date
SE7614401L true SE7614401L (sv) 1977-06-23
SE424730B SE424730B (sv) 1982-08-09

Family

ID=24578600

Family Applications (3)

Application Number Title Priority Date Filing Date
SE7614401A SE424730B (sv) 1975-12-22 1976-12-21 Forfarande for framstellning av natriumcefamandolanhydrat i kristalliserad form
SE8201702A SE441096B (sv) 1975-12-22 1982-03-17 Forfarande for framstellning av natrium cefamandolanhydrat i kristalliserad form
SE8201701A SE443564B (sv) 1975-12-22 1982-03-17 Kristallint metanolat av natriumcefamandol till anvendning vid framstellning av kristallint anhydrat av natriumcefamandol och forfarande for framstellning derav

Family Applications After (2)

Application Number Title Priority Date Filing Date
SE8201702A SE441096B (sv) 1975-12-22 1982-03-17 Forfarande for framstellning av natrium cefamandolanhydrat i kristalliserad form
SE8201701A SE443564B (sv) 1975-12-22 1982-03-17 Kristallint metanolat av natriumcefamandol till anvendning vid framstellning av kristallint anhydrat av natriumcefamandol och forfarande for framstellning derav

Country Status (31)

Country Link
US (1) US4054738A (sv)
JP (2) JPS5282714A (sv)
AR (1) AR213300A1 (sv)
AT (2) AT348678B (sv)
AU (1) AU505924B2 (sv)
BE (1) BE849415A (sv)
CA (1) CA1080696A (sv)
CH (1) CH628348A5 (sv)
CS (1) CS195746B2 (sv)
DD (1) DD128727A5 (sv)
DE (1) DE2654647C2 (sv)
DK (1) DK153156C (sv)
FI (1) FI66008C (sv)
FR (3) FR2361898A1 (sv)
GB (1) GB1565854A (sv)
GR (1) GR65891B (sv)
HU (1) HU172474B (sv)
IL (3) IL50977A (sv)
LU (1) LU76435A1 (sv)
MX (1) MX3840E (sv)
NL (1) NL187483C (sv)
NO (1) NO148887C (sv)
NZ (1) NZ182694A (sv)
OA (1) OA05518A (sv)
PH (1) PH12191A (sv)
PL (1) PL102739B1 (sv)
PT (1) PT65955B (sv)
RO (3) RO75964A (sv)
SE (3) SE424730B (sv)
SU (3) SU637087A3 (sv)
ZA (1) ZA766957B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4168376A (en) * 1978-06-05 1979-09-18 Eli Lilly And Company Process for crystalline sodium cefamandole
US4237279A (en) * 1979-07-27 1980-12-02 Eli Lilly And Company Crystalline 3-hydroxycephalosporin solvates
DE3313816A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
CA1242699A (en) * 1985-02-01 1988-10-04 Bristol-Myers Company Cefbuperazone and derivatives thereof
JPH0677412B2 (ja) * 1985-05-03 1994-09-28 株式会社フジクラ 高圧直流送電用電力ケーブル
JPS629495U (sv) * 1985-07-01 1987-01-21
GB9717629D0 (en) 1997-08-21 1997-10-22 Johnson Matthey Plc Removal of residual organic solvents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3496171A (en) * 1969-02-17 1970-02-17 Lilly Co Eli Process for improving the physical and chemical properties of cephaloglycin
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds
US3692781A (en) * 1971-02-26 1972-09-19 Glaxo Lab Ltd Recovery of pure cephalexin from acidic reaction mixtures
US3819620A (en) * 1972-06-01 1974-06-25 Squibb & Sons Inc 7-(d-alpha-amino-1,4-cyclohexadien-1-ylacet-amido)desacetoxycephalosporanic acid dihydrate
US3862186A (en) * 1972-12-15 1975-01-21 Bristol Myers Co Process for the production of cephalexin monohydrate
US3928592A (en) * 1974-02-22 1975-12-23 Lilly Co Eli Antibiotic pharmaceutical compositions

Also Published As

Publication number Publication date
FR2351984A1 (fr) 1977-12-16
FR2361898B1 (sv) 1980-03-14
HU172474B (hu) 1978-09-28
ATA948976A (de) 1978-07-15
IL50977A (en) 1980-02-29
FR2361898A1 (fr) 1978-03-17
DK153156C (da) 1989-02-20
MX3840E (es) 1981-08-11
CS195746B2 (en) 1980-02-29
AU505924B2 (en) 1979-12-06
RO69709A (ro) 1980-04-15
ZA766957B (en) 1978-06-28
FR2351985B1 (sv) 1980-06-27
CA1080696A (en) 1980-07-01
RO75963A (ro) 1981-02-28
AT348678B (de) 1979-02-26
SU1018585A3 (ru) 1983-05-15
DE2654647A1 (de) 1977-06-30
FR2351985A1 (fr) 1977-12-16
BE849415A (fr) 1977-06-15
AT349148B (de) 1979-03-26
PL102739B1 (pl) 1979-04-30
SU671732A3 (ru) 1979-06-30
SU637087A3 (ru) 1978-12-05
IL50977A0 (en) 1977-01-31
GR65891B (sv) 1980-12-01
AR213300A1 (es) 1979-01-15
FI763682A7 (sv) 1977-06-23
JPS61351B2 (sv) 1986-01-08
PH12191A (en) 1978-11-21
CH628348A5 (de) 1982-02-26
IL57387A0 (en) 1979-09-30
SE8201701L (sv) 1982-03-17
FI66008C (fi) 1984-08-10
JPS5282714A (en) 1977-07-11
LU76435A1 (sv) 1977-06-10
NZ182694A (en) 1978-09-25
US4054738A (en) 1977-10-18
NO148887C (no) 1984-01-04
SE424730B (sv) 1982-08-09
DE2654647C2 (de) 1982-06-24
DD128727A5 (de) 1977-12-07
OA05518A (fr) 1981-04-30
AU2001376A (en) 1978-06-01
FI66008B (fi) 1984-04-30
SE443564B (sv) 1986-03-03
GB1565854A (en) 1980-04-23
NL7614233A (nl) 1977-06-24
SE441096B (sv) 1985-09-09
JPS6183189A (ja) 1986-04-26
IL57386A0 (en) 1979-09-30
NL187483B (nl) 1991-05-16
ATA217578A (de) 1978-08-15
DK575576A (da) 1977-06-23
NO764222L (sv) 1977-06-23
NO148887B (no) 1983-09-26
RO75964A (ro) 1981-02-28
FR2351984B1 (sv) 1980-06-27
PT65955B (en) 1978-06-15
PT65955A (en) 1977-01-01
JPS624393B2 (sv) 1987-01-30
NL187483C (nl) 1991-10-16
DK153156B (da) 1988-06-20
SE8201702L (sv) 1982-03-17

Similar Documents

Publication Publication Date Title
FI67704B (fi) Foerfarande foer framstaellning av ett nytt terapeutiskt anvaendbart kristallint monohydrat av 7-(d-alfa-amino-alfa-(p-hydroxifenyl)acetamido)-3-metyl-3-cefem-4-karboxylsyra
SE464580B (sv) Foerfarande foer framstaellning av nya cefalosporinderivat
SE431986B (sv) Forfarande for framstellning av esterderivat av (6r,7r)-3-karbamoyloximetyl-7-/(z)-2-(fur-2-yl)-2-metoxiiminoacetamido/-cef-3-em-4-karbonsyra
NO161495C (no) Fremgangsmaate for fremstilling av (d-alfa-amino-(p-hydroksyfenyl)acetamido))-gruppeholdige cefalosporansyrederivater.
IT1111686B (it) Procedimento per la produzione di cefalosporine
SE7614401L (sv) Forfarande for framstellning av natriumcefamandolanhydrat i kristalliserad form
SE7602565L (sv) Forfarande for framstellning av en ny kristallin form av ett cefalosporinsalt
SE7902598L (sv) Cephalosporinanaloger
SE417824B (sv) 7-aminocefalosporansyraderivat till anvendning som mellanprodukt for framstellning av cefalosporinderivat
IT1164907B (it) Procedimento per la produzione di cefalosporine
SE427184B (sv) Forfarande for framstellning av 7-aminocefalosporansyraderivat
BE852487A (fr) Derives bis-trimethylsilyle de l'acide 7-(d-mandelamido)-3-(1-methyl-a,2,3,4-terazol-5-yl) thiomethyl-3-cephem-4-carboxylique
ES513929A0 (es) Procedimiento para la obtencion de cefalosporina 7-aca.
NO153259C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme cefalosporinderivater
SE432255B (sv) Forfarande for framstellning av esterderivat av (6r,7r)-3-karbamoyloximetyl-7-((z)-2-(fur-2-yl)-2metoxiiminoacetamido)-cef-3-em-4-karbonsyra
NO800564L (no) Fremgangsmaate for fremstilling av penicillinderivater
IT1065394B (it) Procedimento per la preparazione di penicilline
SU574159A3 (ru) Способ получени моногидрата цефалексина
IT1078470B (it) Procedimento per la produzione di derivati di acido cefalosporanico
SE7709623L (sv) Forfarande for framstellning av prostacyklinderivat
BG21232A3 (bg) Метод за отделяне на цефалоспорин "с"
SE7611375L (sv) Forfarande for framstellning av optiskt aktiva sulfoxider
JPS52122391A (en) Novel penicillins
FR2351983A1 (fr) Procede de preparation de derives de l'acide cephalosporanique
SE8406171L (sv) Klorcefadroxilmonohydrat

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7614401-3

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7614401-3

Format of ref document f/p: F